IDH1 and astrocytoma (excluding glioblastoma): In 2021, WHO re-classified grade 4 tumors to be GBM only if they contained wild-type IDH1/2 independent of the histological grade; otherwise, they are to be considered as IDH mutant astrocytomas (grades 2–4)10.